Pfizer’s New Prostate Cancer Combination Therapy Advances With FDA Priority Review

Pfizer Prostate Cancer Combination Therapy has entered one of the most important phases of its regulatory journey after receiving FDA Priority Review, a designation reserved for medicines that could significantly improve patient care. The development marks a major milestone not…









